Dicrocoeliasis is a widespread hepatic bile duct trematode disease, which parasite both humans and a wide range of grazing herbivores and counts as one of the major threats to livestock production in endemic areas [1, 2]. Dicrocoelium spp. as well as Fasciola spp. designed a group as the food-borne trematodes [3, 4]. The lancet liver fluke, Dicrocoelium dendriticum has been distributed throughout Europe, Asia, North Africa, and North America, known as the major cause of the disease. Its parasite is now recognized as Neglected Tropical Diseases, causing major public health problems as well as significant economic impact. Most D.dendriticum infections cause no symptoms or only minor ones, hence remain undetected. The clinical infection of dicrocoeliasis is normally resulting in mild symptoms, but heavy infections can lead to serious animal health problems [5, 6]. Dicrocoeliasis causes severe pathological changes of the liver and bile system such as abscesses, granulomas, and fibrosis. Cholangitis with the thickened bile ducts appearing as white spots on cut surfaces of the liver was diagnosed. Chronic disease can develop into cirrhosis [7]. There have been only rare documented cases of re-infection. The parasitizing infectious diseases result in abdominal pain; flatulence, dyspepsia, and watery diarrhea have been reported. Besides, infected animals show a slight increase in their bilirubin (7%) and albumin (3%), not related to the worm burden. However, the clinical symptoms are not pathognomonic in harsh infectious and animal scan causes edemas, anemia, icterus, and a reduction in their production [8].
There are narrow therapeutic choices for the treatment of dicrocoeliasis in animals and drugs need to be used as an unapproved indication. It is troublesome to regulate whether anthelmintic drugs applied at dose rates and routes endorsed for grazing herbivores cause able to eradicate liver fluke in a definitive host as well. The possible hazard of either inefficient levels and the danger of expansion of anthelmintic resistance or leading to toxic levels is accordingly high [9, 10].
Currently, there is no vaccine available for the prevention, and hence chemotherapy is one of the most widely used strategies to control dicrocoeliasis. Nevertheless, due to the emergence of resistance and the cost of treating small ruminants, alternative treatments have been seeking [4]. At present, chemical anthelmintic drugs, including Benzimidazole, pro-benzimidazole families, and Albendazole have been widely used. However, these drugs are not easily available in distant rural areas and also have some serious disadvantages such as the development of drug resistance, adverse drug reactions, residual effects, toxicity problems, and high veterinary costs. Albendazole, which can be used to treat dicrocoeliasis, has been reported to be toxic in camelids [9]. For other (pro) benzimidazoles further studies are required concerning the safety in animals since higher dose rates need to be used against D. dendriticum than those used against tapeworms, lungworms, and gastrointestinal nematodes [10]. Therefore, it is vital to design an easily operated and non-invasive compound. In the recent decade, nanoparticles (NPs) due to their defined properties have gained lots of attention and considerable interest which makes them a favorable candidate for anthelmintic application since present antiparasitic drugs have some side effects and their efficacy is not fully proved. Among a wide variety of nanoparticles, Silver nanoparticles (AgNPs) are one of the most vital and fascinating nanomaterials among several metallic nanoparticles that are involved in the biomedical application and created the mass reports in the last years [4, 11]. Notably, dramatic consideration was toward the biomedicine-related appraisal of AgNPs that first invited worldwide consideration as eccentric antimicrobial, antifungal, and antiviral agents. Ag NPs have shown excellent properties against a wide range of microorganisms. One of the most vital and unique applications of AgNPs make them ideal in the field of medicine is using them as antimicrobial agents, as well as for use in nanotoxicology studies [12].
During the past years, AgNPs became one of the most investigated nanostructures that proved to have promised, and interesting characteristics suitable for various unconventional and enhanced biomedical applications [13]. AgNPs are convinced to have legitimate dramatic and countenances capability for the improvement of fiction antimicrobial agents, drug-delivery formulations, identification and diagnosis platforms, biomaterial and medical apparatus blankets, and performance-enhanced therapeutic alternatives [14]. However, their mechanism of action is not completely clarified. Several mechanisms have been assumed for the effect of silver NPs on the cell. First of all, direct contact with microorganisms, the ability to penetrate to cell walls, changing the structure of cell membranes, and finally resulting in cell death. Second of all, by binding to the proteins, in the cell membrane, which is involved in the generation and transportation of APP [15]. Thus, the current study aimed to investigate the in vitro anthelmintic activities of AgONPs, against adult D. dendriticum in comparison with the chemical drug, Closantel, and the negative control, RPMI culture media. Surface alterations to the tegument were evaluated by SEM technique and were applied to investigate the concentration effect of AgONPs and with the impact of different incubation times on the death rate of D.dendriticum in comparison with Closantel. However, to the best of the author’s knowledge, this is the first report on the impact of AgO on the structure and motility of adult D. dendriticum.